Archives

by in
Entry Author Date Location
Vertex Seeks FDA Green Light for Cystic Fibrosis Drug, Second Potential Hit of Big Year 10/19/11 Boston
Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M 10/17/11 San Diego
Boston Xconomists and Area Innovators Gather for Special Xconomy Event: The Photos 10/13/11 Boston
Cocrystal, Led by Icos Vets and Stanford Nobelist, Hunts for Next Big Thing for Hepatitis C 09/22/11 Seattle
Stirring the Pot Once in a While Doesn’t Hurt, and It Could Help Biotech Break its Malaise 09/19/11 National
Cocrystal Discovery Snags $7.5M in Hepatitis C Collaboration With Teva 09/15/11 Seattle
Dramatic Changes in Hepatitis C Treatment Expected to Continue 09/06/11 San Diego
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead 09/06/11 National
The Fall of Pfizer: How Big is Too Big for Pharma Innovation? 08/29/11 National
Xconomist of the Week: Tony Coles’ Journey from Mass General Doctor to SF Biotech CEO 08/18/11 National
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut 07/28/11 Boston
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
aTyr Pharma Looks to Strike Balance Between Nonprofits, and Really Big For-Profits 07/06/11 San Diego
Brightcove Moving to Boston, Looks to Hire 07/05/11 Boston
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Vertex Pays $60M for Alios Drugs, PKE Acquires Dexela, AisleBuyer Grabs $7.5M, & More Boston-Area Deals News 06/15/11 Boston
Vertex Adds New HepC Drugs for $60M 06/13/11 Boston
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News 06/09/11 San Diego
The Quest For Biotech Independence: Maybe It Isn’t So Quixotic After All 06/06/11 National
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug 05/23/11 Boston
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
PerkinElmer Buys Labtronics, Vertex Rival Merck Partners with Genentech, ThermoFisher Acquires Phadia, & More Boston-Area Life Sciences News 05/20/11 Boston
Merck, Genentech Team Up on Hepatitis C Drugs, Raising Ante in Vertex Rivalry 05/17/11 New York
Vertex Signs Boston Lease 05/05/11 Boston
New Health IT Startup Targets Military Programs, Allylix Sniffs New Market for Nootkatone, Biocept Builds Team, & More San Diego Life Sciences News 05/05/11 San Diego
FDA Panel OKs Vertex Drug, Dyax Works With FivePrime, Genzyme Amends Anika Lawsuit, & More Boston-Area Life Sciences News 04/29/11 Boston
Vertex Wins FDA Panel’s Recommendation for New Hepatitis C Drug 04/28/11 Boston
Page 3 of 9 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.